Last $0.01 USD
Change Today 0.00 / 0.00%
Volume 2.5K
IMMCQ On Other Exchanges
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

immunicon corp (IMMCQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/6/13 - $0.02
52 Week Low
05/1/13 - $0.0030
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IMMUNICON CORP (IMMCQ)

Related News

No related news articles were found.

immunicon corp (IMMCQ) Related Businessweek News

No Related Businessweek News Found

immunicon corp (IMMCQ) Details

Immunicon Corporation engages in the development, manufacture, marketing, and sale of cell-based diagnostic and life science research products and service activities with a focus on cancer. The company develops technologies that identify, count, and characterize a small number of circulating tumor cells (CTC) and other rare cells present in a blood sample of a patient. It offers CellTracks AutoPrep system, an automated clinical laboratory instrument that captures, labels, and concentrates cells of interest from a sample of blood; CellSave preservative tube, a specialty blood collection device that enables to draw blood into an evacuated test tube and preserve the blood samples; and CellTracks MagNest cell presentation device for presenting magnetically labeled cells for analysis. The company also provides CellTracks Analyzer II, which is a semi-automated fluorescence microscope for rare cell analysis; and EasyCount system, a point-of-care analyzer that is designed to count specific types of cells in whole blood. In addition, it offers CellSearch circulating tumor cell kits, which are used for monitoring patients with metastatic breast cancer, metastatic colorectal cancer, and metastatic prostate cancer; CellSearch profile kit that is used to enable automated and reproducible isolation of rare cells; CellTracks circulating endothelial cell (CEC) kits and CellTracks CEC subset kits that are used for isolating and counting endothelial cells; and tumor phenotyping reagents for cell characterization. The company sells its products to hospitals, reference laboratories, oncology practices, clinical research organizations, and pharmaceutical/biotechnology companies. The company was founded in 1983 and is based in Huntingdon Valley, Pennsylvania. On June 11, 2008, Immunicon Corp, along with its affiliates filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court. The plan was later approved as Chapter 11 liquidation on November 7, 2008.

88 Employees
Last Reported Date: 03/28/08
Founded in 1983

immunicon corp (IMMCQ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMMCQ:US $0.01 USD 0.00

IMMCQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMMCQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation IMMCQ Industry Range
No financial data is available for IMMCQ.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNICON CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at